Cyanotech Corporation (CYAN)
Market Cap | 2.27M |
Revenue (ttm) | 22.49M |
Net Income (ttm) | -4.62M |
Shares Out | 6.95M |
EPS (ttm) | -0.74 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 3,748 |
Open | 0.326 |
Previous Close | 0.326 |
Day's Range | n/a |
52-Week Range | 0.120 - 1.040 |
Beta | -0.00 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Feb 8, 2024 |
About CYAN
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services. The company sells... [Read more]
Financial Performance
In 2023, Cyanotech's revenue was $23.07 million, a decrease of -0.46% compared to the previous year's $23.18 million. Losses were -$19,900, -99.42% less than in 2022.
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/j/e/press11-2497179.jpg)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4FY24 and Fiscal Year 2024.
![](https://cdn.snapi.dev/images/v1/k/s/press8-2266870.jpg)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY24.
![](https://cdn.snapi.dev/images/v1/2/9/press7-2146730.jpg)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024.
![](https://cdn.snapi.dev/images/v1/l/w/press1-2019297.jpg)
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024.
![](https://cdn.snapi.dev/images/v1/v/u/press12-1998622.jpg)
Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment.
![](https://cdn.snapi.dev/images/v1/o/8/press15-1950534.jpg)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023.
![](https://cdn.snapi.dev/images/v1/z/0/image-7-1811218.jpg)
Top 5 Defensive Stocks That Are Set To Fly
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
![](https://cdn.snapi.dev/images/v1/p/r/press4-1746728.jpg)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced fi...
![](https://cdn.snapi.dev/images/v1/p/r/press10-1627334.jpg)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023
![](https://cdn.snapi.dev/images/v1/o/p/press3-1613630.jpg)
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS
The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology c...
![](https://cdn.snapi.dev/images/v1/p/r/press20-1497931.jpg)
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and dietary supplement products, announced results for 1Q fiscal 2023.
![](https://cdn.snapi.dev/images/v1/p/r/press19-1426084.jpg)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition supplement products, announced financial results for fiscal year 2022
![](https://cdn.snapi.dev/images/v1/p/r/press10-1227609.jpg)
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
![](https://cdn.snapi.dev/images/v1/p/r/press5-1100160.jpg)
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022
![](https://cdn.snapi.dev/images/v1/p/r/press3-959549.jpg)
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022
![](https://cdn.snapi.dev/images/v1/p/r/press11-878236.jpg)
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021
![](https://cdn.snapi.dev/images/v1/c/r/cry82.jpg)
Cyanotech Trades Lower After Reporting Q4 Losses
Cyanotech Corporation (NASDAQ: CYAN) reported fourth-quarter net sales of $30.2 million in fiscal 2019 compared to $34.1 million in 2018.